ICU Medical Inc
$ 142.35
-1.17%
04 Dec - close price
- Market Cap 3,514,146,000 USD
- Current Price $ 142.35
- High / Low $ 144.96 / 141.39
- Stock P/E N/A
- Book Value 86.17
- EPS -0.32
- Next Earning Report 2026-03-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE N/A %
- 52 Week High 175.51
- 52 Week Low 107.00
About
ICU Medical, Inc. is a leading global innovator in the development and manufacturing of advanced medical devices, specializing in infusion therapy and critical care solutions. Headquartered in San Clemente, California, the company is committed to enhancing patient safety and healthcare outcomes through its extensive range of cutting-edge technologies. ICU Medical's diverse product portfolio addresses a broad spectrum of needs within medical environments worldwide, supported by its strategic focus on acquisitions and continuous investment in research and development. This commitment positions ICU Medical to sustain its market leadership and pursue sustainable growth in the ever-evolving healthcare sector.
Analyst Target Price
$180.83
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-05 | 2025-02-25 | 2024-11-12 | 2024-08-07 | 2024-05-07 | 2024-02-27 | 2023-11-06 | 2023-08-07 | 2023-05-08 | 2023-02-27 |
| Reported EPS | 2.03 | 1.43 | 1.72 | 2.11 | 1.59 | 1.56 | 0.96 | 1.57 | 1.57 | 1.88 | 1.74 | 1.6 |
| Estimated EPS | 1.42 | 1.5 | 1.28 | 1.482 | 1.25 | 1 | 0.82 | 1.19 | 1.39 | 1.6 | 1.43 | 1.56 |
| Surprise | 0.61 | -0.07 | 0.44 | 0.628 | 0.34 | 0.56 | 0.14 | 0.38 | 0.18 | 0.28 | 0.31 | 0.04 |
| Surprise Percentage | 42.9577% | -4.6667% | 34.375% | 42.3752% | 27.2% | 56% | 17.0732% | 31.9328% | 12.9496% | 17.5% | 21.6783% | 2.5641% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-04 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.71 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ICUI
2025-11-03 02:36:32
Smiths Group announced it is discontinuing merger discussions with ICU Medical after rejecting a nearly $4 billion offer. The potential union between Smiths Medical and ICU Medical was initially revealed in May, but Smiths Group ultimately declined a cash-and-stock offer valued at $3.67 billion.
2025-10-18 20:26:02
This article provides an in-depth AI-driven analysis of Icu Medical Inc. (NASDAQ: ICUI), highlighting a near-term neutral sentiment amidst mid and long-term weakness. It details specific institutional trading strategies, including long, breakout, and short positions, alongside multi-timeframe signal analysis for support and resistance levels. The analysis points to an exceptional 32.5:1 risk-reward setup, targeting a 9.5% gain versus 0.3% risk.
2025-10-16 10:14:49
Argus has lowered its target price for ICU Medical (ICUI) to $123.00 as of October 15, 2025. The report identifies ICU Medical as a California-based pure-play infusion therapy company providing consumables, systems, and services. The article promotes upgrading to premium research reports for detailed company profiles and trade insights.
2025-10-16 06:10:02
This article provides a financial comparison between ICU Medical (ICUI) and Rockwell Medical (RMTI), examining their institutional and insider ownership, profitability, analyst recommendations, risk and volatility, and valuation and earnings. Rockwell Medical is highlighted as potentially more favorable due to a stronger consensus rating and higher possible upside according to analysts, despite ICU Medical trading at a lower price-to-earnings ratio.
2025-10-16 03:33:00
Artivion (NYSE:AORT) reported an exceptional Q2 with revenues up 15.3% year over year, exceeding analyst expectations and leading its peers in revenue growth and guidance. The medical devices and supplies industry, particularly in cardiology, neurology, and vascular care, saw strong Q2 performance with companies like Artivion, ICU Medical, Penumbra, and Merit Medical Systems reporting solid results despite broader market fluctuations and economic factors. The article highlights individual company performances and industry trends, including the impact of an aging population and technological advancements.
2025-10-14 06:34:27
This article forecasts the Closed System Drug Transfer Device (CSTD) market share and size, highlighting how AI and machine learning are revolutionizing safety, efficiency, and compliance in hazardous drug handling. It discusses key trends for 2025, including universal compatibility systems, needle-free technologies, and smart sensor integration, and lists major companies driving innovation in the sector. The report also covers market barriers, regional analysis, and frequently asked questions about the CSTD market's growth prospects.
